The Physiological Interferon Response. II. Interferon is Present in Lymph but not in Plasma of Healthy Rabbits

References

1. Baron S., Mckerlie L. 1981; Broadly active inhibitor of viruses spontaneously produced by many cell types in culture. Infection and Immunity 32:449–453
   [Google Scholar]
2. Bocci V. 1981a; Production and role of interferon in physiological conditions. Biological Reviews 56:49–85
   [Google Scholar]
3. Bocci V. 1981b; Pharmacokinetic studies of interferons. Pharmacology and Therapeutics 13:421–440
   [Google Scholar]
4. Bocci V. 1982; The physiological interferon response: the sites and the meaning. In Human Lymphokines: Biological Immune Response Modifiers pp 241–255 Edited by Khan A., Hill N. O. New York: Academic Press;
   [Google Scholar]
5. Bollman J. L., Cain J. C., Grindlay J. H. 1948; Techniques for the collection of lymph from the liver, small intestine or thoracic duct of the rat. Journal of Laboratory and Clinical Medicine 33:1349–1352
   [Google Scholar]
6. Cesario T., Goldstein A., Lindsey M., Dumars K., Tilles J. 1981; Antiviral activities of amniotic fluid. Proceedings of the Society for Experimental Biology and Medicine 168:403–407
   [Google Scholar]
7. Destefano E., Friedman R. M., Friedman-Kien A. E., Goedert J. J., Henriksen D., Preble O. T., Sonnabend J. A., Vilcek J. 1982; Acid-labile human leukocyte interferon in homosexual men with Kaposi’s sarcoma and lymphadenopathy. Journal of Infectious Diseases 146:451–455
   [Google Scholar]
8. Finter N. B. 1969; Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assays. Journal of General Virology 5:419–427
   [Google Scholar]
9. Fischer D. G., Koren H. S., Rubinstein M. 1982; Spontaneous production of interferon by a subpopulation of human peripheral blood lymphocytes. The 3rd Annual International Symposium on Interferons, Miami, November, 1982
   [Google Scholar]
10. Gornall A. G., Bardawill C. J., David M. M. 1949; Determination of serum proteins by means of the biuret reaction. Journal of Biological Chemistry 177:751–766
    [Google Scholar]
11. Grasso G., Muscettola M., Bocci V. 1983; The physiological interferon response. I. Cells attached to intrauterine devices release interferon in vitro. Proceedings of the Society for Experimental Biology and Medicine 173:276–280
    [Google Scholar]
12. Halonen P. E., Toivanen P., Nikkari T. 1974; Non-specific serum inhibitors of activity of haemagglutinins of rabies and vesicular stomatitis viruses. Journal of General Virology 22:309–318
    [Google Scholar]
13. Havel R. J., Eder H. A., Bragdon J. H. 1955; The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. Journal of Clinical Investigation 34:1345–1353
    [Google Scholar]
14. Hovanessian A. G., Rollin P., Riviere Y., Pouillart P., Sureau P., Montagnier L. 1981; Protein kinase in human plasma analogous to that present in control and interferon-treated HeLa cells. Biochemical and Biophysical Research Communications 103:1371–1377
    [Google Scholar]
15. Hughes T. K., Blalock J. E., McKerlie M. L., Baron S. 1981; Cell-produced viral inhibitor: possible mechanism of action and chemical composition. Interferon and Immunity 32:454–457
    [Google Scholar]
16. Jakab F., Sugar I., Szabo G. 1980; Cannulation of the cervical thoracic duct in the rat. Lymphology 13:184–185
    [Google Scholar]
17. Kumar S., Baron S. 1981–82; Non-interferon cellular products capable of virus inhibition. In The Interferon System: a Review to 1982 part 1 pp 395–401 Edited by Baron S., Dianzani F., Stanton G. J. Texas Reports on Biology and Medicine; 41:
    [Google Scholar]
18. Langford M. P., Weigent D. A., Stanton G. J., Baron S. 1981; Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays. In Interferons part A pp 339–346 Edited by Pestka S. New York: Academic Press;
    [Google Scholar]
19. Lebon P., Girard S., ThÉpot F., Chany C. 1982; The presence of alpha interferon in human amniotic fluid. Journal of General Virology 59:393–396
    [Google Scholar]
20. Levin S., Hahn T. 1981; Evaluation of the human interferon system in viral disease. Clinical and Experimental Immunology 46:475–483
    [Google Scholar]
21. Matthews T. H. J., Lawrence M. K., Nair C. D. G., Tyrrell D. A. J. 1976; Antiviral activity in milk of possible clinical importance. Lancet ii:1387–1389
    [Google Scholar]
22. Montelaro R. C., Fischinger P. J., Larrick S. B., Dunlop N. M., Ihle J. N., Frank H., Schafer W., Bolognesi D. P. 1979; Further characterization of the oncornavirus inactivating factor in normal mouse serum. Virology 98:20–34
    [Google Scholar]
23. Schattner A., Merlin G., Levin S., Wallach D., Hahn T., Revel M. 1981; Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases. Lancet ii:497–499
    [Google Scholar]
24. Seganti L., Grassi M., Mastromarino P., Pana’ A., Superti F., Orsi N. 1983; Activity of human serum lipoproteins on the infectivity of rhabdoviruses. Microbiologica (in press)
    [Google Scholar]
25. WHO Informal Consultation Report Standardization of Interferons Geneva 14–16 June, 1982, pp 1–25
    [Google Scholar]